HOME >연구분야 >김헌성

김헌성

교 수 김 헌 성 Kim Hun Sung
교수 정보
교육분야 내분비내과학, 의료정보학 TEL 02-3147-8425
연구분야 내분비내과학, 당뇨병,
이상지질혈증, 의료정보학,
디지털 헬스케어, 의료빅데이터,
실제임상근거, 원격의료		 E-mail cadiz74@catholic.ac.kr
소속 내분비내과/의료정보학교실 연구실 이름 -

연구실 소개

연구실 소개
연구실 소개

본 연구실은 EMR data, PGHD 등의 실사용데이터(Real World Data)를 실제 진료 현장에 활용할 수 있도록 하는 연구와 ICT 기술을 의료에 접목하는 디지털 헬스헬스케어, 비대면 진료 등에 관한 연구를 진행한다. 임상과 의료정보를 연결하여 디지털 헬스와 실사용데이터의 임상적인 활용에 많은 경험 및 다양한 임상연구 결과를 보유하고 있다.

학력

학력
연도 교육분야 학과 및 전공 학위
2001 인하대학교 의과대학 의학과 학사
2015 서울대학교 의과대학 의료정보학과 석·박사

경력

경력
연도 기관 직위
현재 가톨릭대학교 의료정보학교실 / 서울성모병원 내분비내과 부교수
2016 ~ 2019 가톨릭대학교 의료정보학교실 / 서울성모병원 내분비내과 연구조교수
2013 ~ 2015 서울성모병원 내분비내과 임상조교수
2008 ~ 2012 서울성모병원 내분비내과 임상강사

학회활동 / 위촉활동

학회활동 / 위촉활동
기간 학회명 / 기관 직위
2023 ~ 한국보건정보통계학회 회장
2019 ~ 빅데이터임상활용연구회 회장
2019 ~ 대한방문케어다학제학회 부회장
2023 ~ 대한내분비학회 빅데이터위원회 이사
2021 ~ 대한내분비학회 평의원
2020 ~ 대한당뇨병학회 평의원
2021 ~ 대한디지털헬스학회 학술이사
2021 ~ 대한의료정보학회 학술이사
2022 ~ 대한심뇌혈관질환예방학회 평의원/특임이사

대표논문

대표논문
번호 논문제목 연결
1 Yu J, Lee J, Lee SH, Cho JH, Kim HS. A Study on Weight Loss Caused as per the Side Effect of Liraglutide. Cardiovasc Ther. 2022;5201684. 교신저자 초록
2 Shin J, Lee J, Ko T, Lee K, Choi Y, Kim HS. Improving Machine Learning Diabetes Prediction Models for the Utmost Clinical Effectiveness. J Pers Med. 2022;12(11):1899. 교신저자 초록
3 Ha J, Yu J, Lee J, Kim HS. The effects and side effects of liraglutide as a treatment for obesity. Cardiovasc Prev Pharmacother. 2022;4(4):142-148. 교신저자 초록
4 Kim H, Jung DY, Lee SH, Cho JH, Yim HW, Kim HS. Retrospective cohort analysis comparing changes in blood glucose level and body composition according to changes in thyroid-stimulating hormone level. J Diabetes. 2022;14(9):620-629. 교신저자 초록
5 Kim H, Jung DY, Lee SH, Cho JH, Yim HW, Kim HS. Long-Term Changes in HbA1c According to Blood Glucose Control Status During the First 3 Months After Visiting a Tertiary University Hospital. J Korean Med Sci. 2022;37(38):e281. 교신저자 초록
6 Baek HS, Park JY, Yu J, Lee J, Yang Y, Ha J, Lee SH, Cho JH, Lim DJ, Kim HS. Characteristics of Glycemic Control and Long-Term Complications in Patients with Young-Onset Type 2 Diabetes. Endocrinol Metab (Seoul). 2022;37(4):641-651. 교신저자 초록
7 Baek HS, Park JY, Yu J, Lee J, Yang Y, Ha J, Lee SH, Cho JH, Lim DJ, Kim HS. Characteristics of Glycemic Control and Long-Term Complications in Patients with Young-Onset Type 2 Diabetes. Endocrinol Metab (Seoul). 2022;37(4):641-651. 교신저자 초록
8 Kim SS, Kim HS. The Impact of the Association between Cancer and Diabetes Mellitus on Mortality. J Pers Med. 2022;12(7):1099. 교신저자 초록
9 Min J, Shinn J, Kim HS. Development of a predictive model for the side effects of liraglutide. Cardiovasc Prev Pharmacother. 2022;4(2):87-93. 교신저자 초록
10 Lee S, Jeon S, Kim HS. A Study on Methodologies of Drug Repositioning Using Biomedical Big Data: A Focus on Diabetes Mellitus. Endocrinol Metab (Seoul). 2022;37(2):195-207. 교신저자 초록
11 Kim HS. Drug Repositioning: Exploring New Indications for Existing Drug-Disease Relationships. Endocrinol Metab (Seoul). 2022;37(1):62-64. 교신저자 초록
12 Kang DY, Kim H, Ko S, Kim H, Shinn J, Kang MG, Byeon SJ, Choi JH, Shin SY, Kim HS. Sodium-Glucose Cotransporter-2 Inhibitor-Related Diabetic Ketoacidosis: Accuracy Verification of Operational Definition. J Korean Med Sci. 2022;37(7):e53. 교신저자 초록
13 Shin J, Kim H, Yim HW, Kim JH, Lee S, Kim HS. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers: New-onset diabetes mellitus stratified by statin use. J Clin Pharm Ther. 2022;47(1):97-103. 교신저자 초록
14 Kyoung DS, Kim HS. Understanding and Utilizing Claim Data from the Korean National Health Insurance Service (NHIS) and Health Insurance Review & Assessment (HIRA) Database for Research. J Lipid Atheroscler. 2022;11(2):103-110. 교신저자 초록
15 Ji YA, Kim HS. Scoping Review of the Literature on Smart Healthcare for Older Adults. Yonsei Med J. 2022;63(Suppl):S14-S21. 교신저자 초록
16 Kim S, Kim EH Kim HS. Physician Knowledge Base: Clinical Decision Support Systems. Yonsei Med J. 2022;63(1):8-15. 교신저자 초록
17 Lee HY, Shin J, Kim H, Lee SH, Cho JH, Lee SY, Kim HS. Association between Lung Function and New-Onset Diabetes Mellitus in Healthy Individuals after a 6-Year Follow-up. Endocrinol Metab (Seoul). 2021;36(6):1254-1267. 교신저자 초록
18 Shin SY, Kim HS. Data Pseudonymization in a Range That Does Not Affect Data Quality: Correlation with the Degree of Participation of Clinicians. J Korean Med Sci. 2021;36(44):e299. 교신저자 초록
19 Park H, Lee DY, Park SY, Min J, Shinn J, Lee DH, Kwon SH, Kim HS, Kim NH. Development of a Predictive Model for Glycated Hemoglobin Values and Analysis of the Factors Affecting It. Cardiovasc Prev Pharmacother. 2021;3(4):106-114. 교신저자 초록
20 Park JI, Lee HY, Kim H, Lee J, Shinn J, Kim HS. Lack of Acceptance of Digital Healthcare in the Medical Market: Addressing Old Problems Raised by Various Clinical Professionals and Developing Possible Solutions. J Korean Med Sci. 2021;36(37):e253. 교신저자 초록
21 Lee S, Kim HS. Prospect of Artificial Intelligence Based on Electronic Medical Records. J Lipid Atheroscler. 2021;10(3):282-290. 교신저자 초록
22 Kim H, Lee SH, Lee H, Yim HW, Cho JH, Yoon KH, Kim HS. Blood Glucose Levels and Body Weight Change After Dapagliflozin Administration. Diabetes Investig. 2021;12(9):1594-1602. 교신저자 초록
23 Ko SJ, Kim HM, Shinn J, Byeon S, Choi JH, Kim HS. Estimation of Sodium Glucose Cotransporter 2 Inhibitors-related Genital and Urinary Tract Infections Via Electronic Medical Records-based Common Data Model. J Clin Pharm Ther. 2021;46(4):975-983. 교신저자 초록
24 Kim EH, Kim HS. Perceptron: Basic Principles of Deep Neural Networks. Cardiovasc Prev Pharmacothers. 2021;3(3):64-72. 교신저자 초록
25 Kim HS. Towards Telemedicine Adoption in Korea: 10 Practical Recommendations for Physicians. J Korean Med Sci. 2021;36(17):e103. 교신저자 초록
26 Jun HR, Kim H, Lee SH, Cho JH, Lee H, Yim HW, Yoon KH, Kim HS. Onset of Hyperkalemia Following Administration of Angiotensin Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker. Cardiovasc Ther. 2021;2021:5935149. 교신저자 초록
27 Lee J, Lee SH, Kim H, Lee SH, Cho JH, Lee H, Yim HW, Yoon KH, Kim HS, Kim JH. Low-density lipoprotein cholesterol reduction and target achievement after switching from statin monotherapy to statin/ezetimibe combination therapy: Real-world evidence. J Clin Pharm Ther. 2021;46:134–142. 교신저자 초록
28 Jung AR, Kim H, Kim HS, Kim C, Choi WS. Exercise Strategies to Prevent Hypoglycemia in Patients with Diabetes. Korean J Fam Med. 2021;42(2):91-95. 교신저자 초록
29 Shin J, Kin H, Kim HS, Kim C, Choi WS. Increasing Individual Target Glucose Levels to Prevent Hypoglycemia in Patients with Diabetes. Korean J Fam Med. 2021;42(4):269-273. 교신저자 초록
30 Shin J, Kin H, Kim HS, Kim C, Choi WS. Increasing Individual Target Glucose Levels to Prevent Hypoglycemia in Patients with Diabetes. Korean J Fam Med. 2021;42(4):269-273. 교신저자 초록
31 Shin J, Kin H, Kim HS, Kim C, Choi WS. Increasing Individual Target Glucose Levels to Prevent Hypoglycemia in Patients with Diabetes. Korean J Fam Med. 2021;42(4):269-273. 교신저자 초록
32 Na HR, Kim HS. Medical Ethics in the Era of Artificial Intelligence Based on Medical Big Data. J Korean Diabetes. 2020;21(3):126-129. 교신저자 초록
33 Lee J, Kim HS, Kim J. Out-of-Hospital Data: Patient Generated Health Data. J Korean Diabetes. 2020;21(3):149-155. 교신저자 초록
34 Kim HS, Apprehensions about Excessive Belief in Digital Therapeutics – Points of Concern Excluding Merits. J Korean Med Sci. 2020;35(45):e373. 교신저자 초록
35 Kim HS, Yoon KH. Lessons from Use of Continuous Glucose Monitoring Systems in Digital Healthcare. Endocrinol Metab (Seoul). 2020;35:541-548. 교신저자 초록
36 Kim TM, Kim H, Lee SH, Cho JH, Lee H, Yim HW, Yoon KH, Kim HS. Characteristics of Hypoglycemic Diabetic Patients Visiting the Emergency Room. Cardiovasc Ther. 2020;2020:3612607. 교신저자 초록
37 Choe S, Shinn J, Kim HS, Kim JH. Changes in Target Achievement Rates After Statin Prescription Changes at a Single University Hospital. Cardiovasc Prev Pharmacother. 2020;2(3):103-111. 교신저자 초록
38 Kim H, Lee SH, Cho JH, Lee H, Yim HW, Yoon KH, Kim HS. Discontinuation rate and reason for discontinuation after sodium glucose cotransporter 2 inhibitors prescription in real clinical practice. J Clin Pharm Ther. 2020;45:1271–1277. 교신저자 초록
39 Jung AR, Park JI, Kim HS. Physical activity for prevention and management of sleep disturbances. Sleep Med Res. 2020;11(1):15-18. 교신저자 초록
40 Yoo HJ, Shinn J, Kim HS, Managing Sleep Disorders through Lifestyle Choices: A Focus on Nutrition. Korean J Clin Geri. 2020;21(1):9-15. 교신저자 초록
41 Kim HS. Lessons from Temporary Telemedicine Initiated owing to Outbreak of COVID-19. Healthc Inform Res. 2020;26(2):159-161. 교신저자 초록
42 Lee J, Kim TM, Kim H, Lee SH, Cho JH, Lee H, Yim HW, Yoon KH, Kim HS. Differences in Clinical Outcomes between Patients with and without Hypoglycemia during Hospitalization: A Retrospective Study Using Real-World Evidence. Diabetes Metab J. 2020;44(4):555-565. 교신저자 초록
43 Kim HS. Decision-Making in Artificial Intelligence: Is It Always Correct? J Korean Med Sci. 2020;35(1):e1. 교신저자 초록
44 Shin J, Kim HS, Kim TM, Kim H, Lee SH, Cho JH, Lee H, Yim HW, Yoon KH. The short-term effects of angiotensin II receptor blockers on albuminuria and renal function in Korean patients. Basic Clin Pharmacol Toxicol. 2020;126(5):424-431. 교신저자 초록
45 Kim HS, Kim DJ, Yoon KH. Medical Big Data Is Not Yet Available: Why We Need Realism Rather than Exaggeration. Endocrinol Metab (Seoul). 2019;34(4):349-354. 교신저자 초록
46 Baik SY, Kim H, Yang SJ, Kim TM, Lee SH, Cho JH, Lee H, Yim HW, Yoon KH, Kim HS. Long-term effects of various types of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on changes in glomerular filtration rate in Korea. Front Med. 2019;13(6):713-722. 교신저자 초록
47 Lee J, Kim HS, KIM DJ. Recent Technology-Driven Advancements in Cardiovascular Disease Prevention. Cardiovasc Prev Pharmacother. 2019;1(2):43-49. 교신저자 초록
48 Kim HS, Kim DJ. Dementia Research Using Healthcare Big Data. Dement Neurocogn Disord. 2019;18(3):73-76. 교신저자 초록
49 Kim H, Baik SY, Yang SJ, Kim TM, Lee SH, Cho JH, Choi IY, Kim JH, Yoon KH, Kim HS. Clinical experiences and case review of angiotensin II receptor blocker-related angioedema in Korea. Basic Clin Pharmacol Toxicol. 2019;124(1):115-122. 교신저자 초록
50 Kim HS. Serum Uric Acid and Metabolic Syndrome: a Retrospective Cohort Study. J Korean Med Sci. 2019;34(48):e324. 교신저자 초록
51 Kim HS, Lee SH, Kim TM, Kim JH. Developing a multi-center clinical data mart of ACEI and ARB for real-world evidence (RWE). Clin Hypertens. 2018;24:18. 교신저자 초록
52 Kim H, Lee H, Kim TM, Yang SJ, Baik SY, Lee SH, Cho JH, Lee H, Yim HW, Choi IY, Yoon KH, Kim HS. Change in ALT levels after administration of HMG-CoA reductase inhibitors to subjects with pretreatment levels three times the upper normal limit in clinical practice. Cardiovasc Ther. 2018;36(3):e12324. 교신저자 초록
53 Kim H, Lee H, Yim HW, Kim HS. Association of serum 25-hydroxyvitamin D and diabetes-related factors in Korean adults without diabetes: The Fifth Korea National Health and Nutrition Examination Survey 2010-2012. Prim Care Diabetes. 2018;12(1):59-65. 교신저자 초록
54 Jeong YJ, Kim H, Baik SJ, Kim TM, Yang SJ, Lee SH, Cho JH, Lee H, Yim HW, Choi IY, Yoon KH, Kim HS. Analysis and comparison of the cost-effectiveness of statins according to the baseline low-density lipoprotein cholesterol level in Korea. J Clin Pharm Ther. 2017;42(3):292-300. 교신저자 초록
55 Kim TM, Kim H, Jeong YJ, Baik SJ, Yang SJ, Lee SH, Cho JH, Lee H, Yim HW, Choi IY, Yoon KH, Kim HS. The differences in the incidence of diabetes mellitus and prediabetes according to the type of HMG-CoA reductase inhibitors prescribed in Korean patients. Pharmacoepidemiol Drug Saf. 2017;26(10):1156-1163. 교신저자 초록
56 Kim H, Kim N, Lee DH, Kim HS. Analysis of National Pharmacovigilance Data Associated with Statin Use in Korea. Adverse Drug Reactions with Statins. Basic Clin Pharmacol Toxicol. 2017;121(5):409-413. 교신저자 초록
57 Kim KJ, Jun CH, Lee H, Kim HS. Analyzing association between low-density lipoprotein reduction by statin and adherence to medication using national health insurance service-national sample cohort (NHIS-NSC). Journal of the Korean Data & Information Science Society. 2017;28:1027-1041. 교신저자 초록
58 Yang SJ, Yoon KH, Kim HS. Mobile Health for Health Management of the Elderly. Korean J Clin Geri. 2016;17(1):1-6. 교신저자 초록
59 Kim HS, Min J, Shinn J, Hong OK, Son JW, Lee SS, Kim SR, Yoo SJ. Modeling of Changes in Creatine Kinase after HMG-CoA Reductase Inhibitor Prescription. Cardiovasc Prev Pharmacother. 2021;3(4):115-123. 초록
60 Kim HS, Kwon IH, Cha WC. Future and Development Direction of Digital Healthcare. Healthc Inform Res. 2021;27(2):95-101. 초록
61 Kim HS, Kim H, Lee SH, Kim JH. Comparative analysis of the efficacy of angiotensin II receptor blockers for uric acid level change in asymptomatic hyperuricemia. J Clin Pharm Ther. 2020;45(6)1264-1270. 초록
62 Kim HS, Kim JH. Proceed with Caution When Using Real World Data and Real World Evidence. J Korean Med Sci. 2019;34(4):e28. 초록
63 Kim HS, Lee S, Kim JH. Real-world Evidence versus Randomized Controlled Trial: Clinical Research Based on Electronic Medical Records. J Korean Med Sci. 2018;33(34):e213. 초록
64 Kim HS, Lee H, Lee SH, Jeong YJ, Kim TM, Yang SJ, Baik SJ, Kim H, Lee SH, Cho JH, Choi IY, Yoon KH, Kim JH. Use of Moderate-Intensity Statins for Low-Density Lipoprotein Cholesterol Level above 190 mg/dL at Baseline in Koreans. Basic Clin Pharmacol Toxicol. 2017;121(4):272-278. 초록
65 Kim HS, Kim H, Jeong YJ, Lee H, Yim HW, Kim JI, Moon IS, Kim JY. Comparative Analysis of the Suspected Heparin-Induced Thrombocytopenia Level in Korea. Basic Clin Pharmacol Toxicol. 2017;121(4):360-367. 초록
66 Kim H, Kim HS, Ko H, Choi J, Cho NH. Analysis of inappropriate medication use and drug interactions in older people in South Korea. Int J Clin Pharmacol Ther. 2017;55(11):847-852. (co-1stauthor) 초록
67 Hong JY, Kim HS, Choi IY, Pilot Algorithm Designed to Help Early Detection of HMG-CoA Reductase Inhibitor-Induced Hepatotoxicity. Healthc Inform Res. 2017;23(03):199-207 (co-1stauthor) 초록
68 Kim HS, Kim H, Jeong YJ, Kim TM, Yang SJ, Baik SJ, Lee SH, Cho JH, Choi IY, Yoon KH. Development of Clinical Data Mart of HMG-CoA Reductase Inhibitor for Varied Clinical Research. Endocrinol Metab (Seoul). 2017;32(1):90-98. 초록
69 Kim HS, Kim H, Yang HK, Lee EY, Jeong YJ, Kim TM, Yang SJ, Baik SY, Lee SH, Cho JH, Choi IY, Yim HW, Cha BY. Physician-Directed Diabetes Education without a Medication Change and Associated Patient Outcomes. Diabetes Metab J. 2017;41(3):187-194. 초록
70 Kim HS, Yang SJ, Jeong YJ, Kim YE, Hong SW, Cho JH. Satisfaction Survey on Information Technology-Based Glucose Monitoring System Targeting Diabetes Mellitus in Private Local Clinics in Korea. Diabetes Metab J. 2017;41(3):213-222. 초록
71 Kim HS, Kim H, Lee H, Park B, Park S, Lee SH, Cho JH, Song H, Kim JH, Yoon KH, Choi IY. Analysis and comparison of statin prescription patterns and outcomes according to clinical department. J Clin Pharm Ther. 2016;41(1):70-77. 초록
72 Kim HS, Lee SH, Kim H, Lee SH, Cho JH, Lee H, Yim HW, Kim SH, Choi IY, Yoon KH, Kim JH. Statin-related aminotransferase elevation according to baseline aminotransferases level in real practice. J Clin Pharm Ther. 2016;41(3):266-272. 초록
73 Kim HS, Kim H, Jeong YJ, Yang SJ, Baik SJ, Lee H, Lee SH, Cho JH, Choi IY, Yim HW, Yoon KH. Comparative analysis of the efficacy of omega-3 fatty acids for hypertriglyceridaemia management in Korea. J Clin Pharm Ther. 2016;41(5):508-514. 초록
74 Kim HS. Lee H, Park B, Park S, Kim H, Lee SH, Cho JH, Yoon KH, Cha BY, Kim JH, Choi IY. Comparative analysis of the efficacy of low- and moderate-intensity statins in Korea. Int J Clin Pharmacol Ther. 2016;54(11):864-871. 초록
75 Kim HS, Sun C, Yang SJ, Sun L, Li F, Choi IY, Cho JH, Wang G, Yoon KH. Randomized, open-label, parallel group study to evaluate the effect of internet-based glucose management system on subject with diabetes in China. Telemedicine and e-Health. 2016;22(8):666-674. 초록
76 Kim H. Kim HS, J. D. Bowman, Cho NH. Comparing diabetic patient characteristics related to stated medication adherence in a rural vs. urban community in Korea. J Clin Pharm Ther. 2016;41(1):40-6 (Co-1stauthor) 초록
77 Kim HS, Jeong YJ, Baik SJ, Yang SJ, Kim TM, Kim H, Lee H, Lee SH, Cho JH, Choi IY, Yoon KH. Social Networking Services-Based Communicative Care for Patients with Diabetes Mellitus in Korea. Appl Clin Inform. 2016;7(3):899-911. 초록
78 Kim HS, Cho JH, Yoon KH. New Directions in Chronic Disease Management. Endocrinol Metab (Seoul). 2015;30(2):159-166. 초록
79 Kim HS, Kim H, Lee S, Lee KH, Kim JH, Current Clinical Status of Telehealth in Korea: Categories, Scientific Basis, and Obstacles. Healthc Inform Res. 2015;21(4):244-250. 초록
80 Kim HS, Lee KH, Kim H, Kim JH. Using mobile phones in healthcare management for the elderly. Maturitas. 2014;79(4):381-388. 초록
81 Kim HS, Hwang YJ, Lee JH, Oh HY, Kim YJ, Kwon HY, Kang HS, Kim HA, Park RW, Kim JH. Future prospects of health management system using cellular phone. Telemedicine and e-Health. 2014;20(6):544-551. 초록
82 Kim HS, Choi WA, Baek EK, Yun A Kim YA, Yang SJ, Choi IY, Yoon KH, Cho JH. Efficacy of the Smartphone-based Glucose management application according to User’s satisfaction. Diabetes Metab J. 2014;38(3):204-210. 초록
83 Kim HS, Yoon KH, Cho JH. Diurnal Heart Rate Variability Fluctuations in Normal Volunteers. J Diabetes Sci Technol. 2014;8(2):431-433. 초록
84 Kim HS, Shin JA, Lee SH, Kim ES, Cho JH, Son HY, Yoon KH. A Comparative Study of the Effects of a Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability in Patients with Type 2 Diabetes with Inadequate Glycemic Control on Metformin. Diabetes Technol Ther. 2013;15(10):810-6. 초록
85 Kim HS, Shin JA, Chang JS, Cho JH, Son HY, Yoon KH. Continuous glucose monitoring: current clinical use. Diabetes Metab Res Rev. 2012;28 Suppl 2:73-78. 초록